We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Cells Harvested From Urine to Enable Earlier Kidney Disease Detection

By LabMedica International staff writers
Posted on 20 Mar 2024
Print article
Image: Cells harvested from urine offers potential for non-invasive diagnostic testing of kidney disease (Photo courtesy of 123RF)
Image: Cells harvested from urine offers potential for non-invasive diagnostic testing of kidney disease (Photo courtesy of 123RF)

Detecting kidney disease late can lead to severe and even life-threatening issues. Now, new research has found that the genes expressed in human cells harvested from urine closely match those in the kidney, suggesting that these cells could offer a non-invasive approach to better understanding kidney health. This discovery could allow the diagnosis of kidney problems without doing biopsies, making it possible to detect kidney disease earlier and more easily.

A team of scientists led by the University of Manchester (Manchester, UK) used a method called transcriptomics to measure the levels of about 20,000 genes in each cellular sediment sample of urine. Transcriptomics helps scientists see which genes are active or inactive, providing insights into how cells adapt to changes in their environment. This molecular-level understanding can lead to more accurate diagnoses and better patient outcomes. The team also had access to the world's largest collection of human kidney samples from surgeries or biopsies, known as the Human Kidney Tissue Resource, at the University of Manchester.

The researchers used advanced computational methods to extract both DNA and RNA from the samples and analyze data from previous large-scale studies on blood pressure. They discovered that a low level of a particular gene in the kidney could be a cause of high blood pressure. This gene, ENPEP, produces an enzyme called aminopeptidase and is crucial for blood pressure regulation. It was among the 399 genes identified in the study whose levels in the kidney have a direct impact on blood pressure readings.

“This study shows that using cutting edge technology we are able to combine different unique datasets together using genetics as a connector,” said Professor Maciej Tomaszewski, Chair of Cardiovascular Medicine at The University of Manchester, who led the study. “One of the most exciting findings of that is we discover how cells harvested from urine have the potential to provide a glimpse into the molecular operation of the human kidney. That gives us an exciting avenue of research for non-invasive diagnostic testing.”

“There is a well-known link between the heart and the kidneys in regulating blood pressure,” said Professor Bryan Williams, Chief Scientific and Medical Officer at the British Heart Foundation which funded the study. “This study uses cutting-edge scientific techniques to analyze genes present in kidney cells that are normally expelled in the urine. Analyzing these cells could reveal which genes may be playing a key role in people with high blood pressure, and could potentially offer clinicians a new, non-invasive way to help diagnose those with kidney disease early on.”

Related Links:
University of Manchester

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Epstein-Barr Virus Test
Mononucleosis Rapid Test
New
TRAcP 5b Assay
TRAcP 5b (BoneTRAP) Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.